NeuroSense Therapeutics Ltd. (NRSNW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
分析师预估 每股收益(EPS)为 $-0.65 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.55 vs 预期 $-0.65 (超预期 +15.4%). 分析师准确度: 82%.
